2021 Press Releases

11-15-21 ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2021

11-09-21 ImmuCell to Announce Unaudited Financial Results for the Third Quarter Ended September 30, 2021

10-06-21 ImmuCell Announces Record Preliminary, Unaudited Sales Results for Third Quarter of 2021

09-14-21 Raffael Lichdi, DVM Joins ImmuCell’s Sales & Marketing Team

08-24-21 ImmuCell Required to Prepare Second Submission of Final Major Technical Section for Re-Tain®

08-12-21 ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2021

08-05-21 ImmuCell to Announce Unaudited Financial Results for the Second Quarter Ended June 30, 2021

07-07-21 ImmuCell Announces Strong Preliminary, Unaudited Sales Results for Second Quarter of 2021

05-19-21 ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

05-13-21 ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2021

05-06-21 ImmuCell to Announce Unaudited Financial Results for the First Quarter Ended March 31, 2021

04-14-21 ImmuCell Closes $4,250,000 Equity Financing

04-07-21 ImmuCell Announces Preliminary, Unaudited Sales Results for First Quarter of 2021

02-22-21 ImmuCell Makes Important Regulatory Submission and Announces Unaudited Financial Results for the Year Ended December 31, 2020

02-16-21 ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2020

01-07-21 ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2020